Evidence map›Paper›PMID 42033229›Full record

ArticleNucleic acids research2026

Dual role of ZIC2 during neural induction: from priming transcription factor to enhancer activator.

María Mariner-Faulí, Víctor Sánchez-Gaya, Sarah Malika Robert, Patricia Respuela, Sara de la Cruz-Molina, Sara Lobato-Moreno, Matteo Trovato, Karin D Prummel, Kyung-Min Noh, Judith B Zaugg and 1 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

María Mariner-FaulíInstitute of Biomedicine and Biotechnology of Cantabria, CSIC/Universidad de Cantabria, Santander, 39011, Spain.
Víctor Sánchez-GayaInstitute of Biomedicine and Biotechnology of Cantabria, CSIC/Universidad de Cantabria, Santander, 39011, Spain.
Sarah Malika RobertInstitute of Biomedicine and Biotechnology of Cantabria, CSIC/Universidad de Cantabria, Santander, 39011, Spain.
Patricia RespuelaInstitute of Biomedicine and Biotechnology of Cantabria, CSIC/Universidad de Cantabria, Santander, 39011, Spain.
Sara de la Cruz-MolinaCenter for Molecular Medicine Cologne, University of Cologne, Cologne, 50931, Germany.
Sara Lobato-MorenoEuropean Molecular Biology Laboratory, Molecular Systems Biology Unit, Heidelberg, 69117, Germany.
Matteo TrovatoEuropean Molecular Biology Laboratory, Molecular Systems Biology Unit, Heidelberg, 69117, Germany.
Karin D PrummelEuropean Molecular Biology Laboratory, Molecular Systems Biology Unit, Heidelberg, 69117, Germany.
Kyung-Min NohEuropean Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, 69117, Germany.
Judith B ZauggEuropean Molecular Biology Laboratory, Molecular Systems Biology Unit, Heidelberg, 69117, Germany.
Álvaro Rada-IglesiasInstitute of Biomedicine and Biotechnology of Cantabria, CSIC/Universidad de Cantabria, Santander, 39011, Spain.ORCID 0000-0001-7137-1341

Funding

EMBL Heidelberg PID2021-123030NB-I00 (AR-I)European Commission Chromrare HORIZON- MSCA-2021-DN-01-101073334 (AR-I)European Research Council ENHPATHY H2020-MSCA-ITN-2019-860002 (AR-I)
6 · The paper itself

Abstract

Defects in ZIC2, a member of the Zinc Finger of the Cerebellum family of transcription factors (TFs), cause holoprosencephaly, a congenital brain malformation characterized by the defective cleavage of cerebral hemispheres. However, the gene regulatory network (GRN) controlled by ZIC2 during neural development remains largely unexplored. Here, we combined a mouse embryonic stem cell (mESC) in vitro differentiation model toward anterior neural progenitors with genome editing and genomic methods to elucidate the ZIC2 GRN. We found that ZIC2 is dispensable in mESC due to compensation by ZIC3. In contrast, during neural induction ZIC2 directly controls the expression of master regulators implicated in the patterning and morphogenesis of specific brain regions (e.g. midbrain and roof plate). Mechanistically, ZIC2 plays a dual role in neural differentiation: during pluripotency exit, ZIC2 binds de novo to distal enhancers and increases their chromatin accessibility; during neural induction, ZIC2 is essential for the activation of a subset of the previously primed enhancers, which in turn control the expression of neural patterning regulators and signalling pathways (i.e. WNT) that prevent premature neuronal differentiation. Therefore, by sequentially acting as a promiscuous priming TF and selective enhancer activator, ZIC2 canalizes pluripotent cells toward neural progenitors with rostro-dorsal identities.

Indexed as

NeurogenesisTranscription FactorsAnimalsCell DifferentiationEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalGene Regulatory NetworksHomeodomain ProteinsMiceMouse Embryonic Stem CellsHomeodomain ProteinsTranscription FactorsZic2 protein, mouseZic3 protein, mouse

Identifiers

PMID42033229
PMCPMC13109728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.